If you have any questions or would like to know if we can help your business with its innovation challenges, please contact us here or email us at [email protected] If you have any questions or would like to know if we can help your business with its innovation challenges, please contact us here or email us at [email protected]
Sterling JK, Adetunji MO, Guttha S, et al
A.DincerF.ThakkarB.Sahin-EfeA.et al (2016b)
Actual cost varies by dose, vial duration, and refill timing
In June 2023, Pfizer announced the progress of its oral late-stage glucagon-like peptide-1 receptor agonist (GLP-1-RA) candidate toward first clinical development for the potential treatment of adults with obesity and Type 2 diabetes mellitus (T2DM)
State-licensed pharmacies must stop making most compounded semaglutide (copies of Novo Nordisks Wegovy and Ozempic) by April 22, and larger outsourcing pharmacies by May 22, or when district court rules on a pending injuction whichever is first